MYD88 and triple-A syndrome: Owens et al11 recently reported that deficiency of TLR4 or MyD88 reduced both angiotensin II (AngII)–induced atherosclerosis and AAA formation, indicating that innate immune signaling may contribute to the pathogenesis of AAA.